Charleston hospital system will mandate COVID vaccines for workers following FDA approval

Compliments of Post and Courier

Another hospital system in the Lowcountry will soon mandate that workers get a COVID-19 vaccine as a condition of employment. 

Roper St. Francis alerted its approximately 6,000 employees of the impending requirement on Aug. 24. The announcement comes a day after the federal Food and Drug Administration granted full approval to the Pfizer vaccine for people 16 and older and comes amid a new surge of COVID patients flooding hospitals and intensive care units across South Carolina. 

“We are proceeding with this requirement because we care about you and our patients,” Roper St. Francis wrote in an email to employees. “This mandate is unanimously supported by the RSFH Board of Directors, senior leadership and our medical staff.”

Roper St. Francis staff who are not fully vaccinated must get their first dose by Oct. 1 and their second dose by Nov. 1. Employees who intend to file medical or religious exemptions to the mandate must do so by Sept. 17. Roper St. Francis spokesman Andy Lyons said the details of those exemption forms are still being finalized and he did not yet know if employees who developed natural immunity through a previous COVID-19 infection would qualify for a medical exemption. 

Lyons said approximately 1,500 of the system’s 6,000 employees have not been vaccinated yet. 

The Medical University of South Carolina and the Ralph H. Johnson VA Medical Center in Charleston already require employees to be vaccinated. In July, MUSC fired five employees who declined to be vaccinated. Vaccines for Trident Health employees remain optional, but encouraged. 

In the letter to employees, Roper St. Francis leaders said more than 3,600 health care workers across the country died during the first year of the pandemic and explained that unvaccinated hospital and health care employees create more risks for patients. 

According to the latest hospital census, across all four Roper St. Francis hospitals, all but 14 of the 107 COVID-19 inpatients are unvaccinated. None of the vaccinated patients who are hospitalized are on ventilators. 

Join now to enjoy expanded member benefits!

Enjoy exclusive member content, special events, savings, networking and more

Paige Durham

SCbio is pleased to welcome Paige Durham to the team as communications coordinator to creatively and effectively communicate the value of the life science association’s programs and initiatives.

Durham will be responsible for developing and distributing high-quality content across multiple communications channels to build, advance and grow South Carolina’s life sciences industry, a key business sector for economic prosperity for the Palmetto State.

“SCbio is excited to welcome Paige to our team as our new communications coordinator. Paige brings fresh ideas and a strong background in communications that will be invaluable as we continue to strengthen our engagement with our audience,” said SCbio President and CEO James Chappell. “We are confident that her skills and experience will be crucial in advancing our communication strategies and supporting our mission.”

Before joining SCbio, Durham was the Membership and Communications Manager at the South Carolina Pharmacy Association (SCPhA), where she used her photography, design and writing skills to create content tailored to pharmacy professionals. Durham’s effective communication skills guaranteed the delivery of brand-specific material that captured the eye of her audience.

During her time at SCPhA, Durham created and edited the Palmetto Pharmacist Journal, using her creative vision to showcase members, educational institutions and industry news. Her communications efforts successfully gained new followers for the organization over the course of a year, increasing brand visibility and promoting the pharmacy profession.

Durham holds a Bachelor of Science in hospitality and tourism management and a Bachelor of Science in business administration from the College of Charleston.

Tamia Sumpter

Tamia is a driven senior undergraduate Bioengineering student currently enrolled at Clemson University. With a strong foundation in her field, she has honed her skills through hands-on experience in research and development at Eli Lilly & Company. During her time in the ADME department, Tamia contributed significantly by working on siRNAs and their applications in finding In Vitro-In Vivo Correlation (IVIVC). Looking ahead, Tamia has set her sights on a promising career in law. She aspires to specialize in Intellectual Property Law, with a particular focus on serving as in-house counsel for leading medical device or pharmaceutical companies. Her enthusiasm for this role is palpable as she prepares to embark on her legal journey! She is also a proud member of the Omicron Phi chapter of Delta Sigma Theta Sorority, Inc., PEER Mentor for Clemson PEER/WiSE, and currently serves as the President of Clemson Bioengineering Organization (CBO). With her unique blend of scientific knowledge and legal interests, Tamia is poised to make a meaningful impact in the healthcare and life sciences industries.